Literature DB >> 2980018

Clinical experience with expanded polytetrafluoroethylene Gore-Tex surgical membrane for pericardial closure: a study of 110 cases.

C Minale1, S Nikol, G Hollweg, C Mittermayer, B J Messmer.   

Abstract

Complete closure of the pericardium after cardiac operations has the advantage of avoiding injury of the heart and great vessels during reoperation. Between 1985 and 1987, the pericardium was closed with Gore-Tex Surgical Membrane (SM) in a selected series of 110 patients 1 month to 76 years of age. Fifty-three patients had congenital heart lesions and 57 patients had acquired heart disease. Overall hospital mortality was 3/110 cases. In no instance was there a relationship between occurrence of death and pericardial closure with SM. There was one episode of cardiac tamponade on the seventh postoperative day. One patient developed fever and leukocytosis due to a mediastinal hematoma. During a mean follow-up of 15 months, four patients had to be reoperated upon three, four, eight weeks, and eight months after primary operation. The anterior wall of the heart had no adhesion with the SM and the other parts of pericardium could be dissected easily. Scanning electron microscopic examination of the explanted SM patches showed neither cellular ingrowth nor immunocompetent cellular elements. The Gore-Tex Surgical Membrane has the advantages of easy availability and lack of reaction between its surface and the epicardium and pericardium. We believe its routine use should be encouraged in patients with high probability of reoperation after repair of complex cardiac anomalies, implantation of bioprostheses, coronary revascularization for one- or two-vessel disease, and repair of degenerative disease of the ascending aorta.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2980018     DOI: 10.1111/j.1540-8191.1988.tb00239.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  6 in total

Review 1.  Pre-transplant ventricular assist device explant.

Authors:  Espeed Khoshbin; Stephan Schueler
Journal:  Ann Cardiothorac Surg       Date:  2018-01

2.  Use of polytetrafluoroethylene surgical membrane as a pericardial substitute in the correction of congenital heart defects.

Authors:  M Loebe; V Alexi-Meskhishvili; Y Weng; G Hausdorf; R Hetzer
Journal:  Tex Heart Inst J       Date:  1993

3.  Suboccipital decompression for Chiari I malformation: outcome comparison of duraplasty with expanded polytetrafluoroethylene dural substitute versus pericranial autograft.

Authors:  Frank J Attenello; Matthew J McGirt; Giannina L Garcés-Ambrossi; Kaisorn L Chaichana; Benjamin Carson; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

4.  Gelatin/Polycaprolactone Electrospun Nanofibrous Membranes: The Effect of Composition and Physicochemical Properties on Postoperative Cardiac Adhesion.

Authors:  Xingang Wang; Li Xiang; Yongxuan Peng; Zihao Dai; Yuqing Hu; Xiaoting Pan; Xingliang Zhou; Hao Zhang; Bei Feng
Journal:  Front Bioeng Biotechnol       Date:  2021-12-06

Review 5.  Bioresorbable Polymeric Scaffold in Cardiovascular Applications.

Authors:  Daniel Wee Yee Toong; Han Wei Toh; Jaryl Chen Koon Ng; Philip En Hou Wong; Hwa Liang Leo; Subramanian Venkatraman; Lay Poh Tan; Hui Ying Ang; Yingying Huang
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

6.  Recurrent Cardiac Constriction after Implantation of an Expanded Polytetrafluoroethylene Surgical Membrane.

Authors:  Paul-Cătălin Puiu; Matthias Siepe; Wolfgang Zeh; Emmanuel Zimmer
Journal:  Thorac Cardiovasc Surg Rep       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.